Replies to post #47573 on Biotech Values

[DewDiligence]

FluMist now FDA-approved for self-administration:

https://www.prnewswire.com/news-releases/fda-approves-nasal-spray-influenza-vaccine-for-self--or-caregiver-administration-302254354.html

With the label expansion, Flumist can be administered by a healthcare provider or ordered through a pharmacy for self-administration at home.

The approval is for ages 2-49 (same as the prior label). The low upper bound of the age range (49) is due to FluMist’s containing a weakened, but live, flu virus.